Advertisement

Sepsis: Clinical Approach, Evidence-Based at the Bedside

  • F. J. Hurtado
  • M. Buroni
  • J. Tenzi

Abstract

Sepsis is a common disease in intensive care medicine representing almost one third of patient admissions. Its incidence has substantially increased over the past decades and overall mortality has declined during this period of time. It was reported that sepsis incidence increased from 82.7 to 240.4 per 100,000 population between 1979–2000. At the same time, sepsis global mortality decreased from 27.8 to 17.9% [1, 2, 3]. However, the absolute number of deaths significantly increased from 21.9 to 43.9 per 100,000 population. Male gender, some chronic diseases like diabetes, immunosuppressive states, human immunodeficiency virus infections, and malignancies are factors that increase the risk for sepsis. Some particular conditions like progressive number of organ dysfunctions, in-hospital-acquired infections and increasing age are associated with higher risk of death [1,4]. On the other hand, septic shock mortality only diminished from 61.6 to 53.1% [5]. This slight decline in mortality observed during recent decades could be attributable to improvements in supportive care and/or avoidance of iatrogenic complications. For example, the instrumentation of early goal resuscitation protocols not aiming at supranormal targets for cardiac output and oxygen delivery, and the use of lung protective strategies could explain at least in part this favorable change. Other strategies directed to treat the pathophysiological mechanisms involved in the septic process like recombinant human-activated protein-C (rhAPC), have also contributed to improve survival. However, mortality remains unacceptably high and further improvement in sepsis management is needed.

Keywords

Septic Shock Severe Sepsis Septic Patient Sequential Organ Failure Assessment Intensive Insulin Therapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Martin GS, Mannino D, Eaton S et al (2003) The epidemiology of sepsis in the United States from 1979 through 2000. N Engl J Med 348:1546–1554CrossRefPubMedGoogle Scholar
  2. 2.
    Angus D, Linde-Zwirble W, Lidicker J et al (2001) Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated cost of care. Crit Care Med 29:1303–1310CrossRefPubMedGoogle Scholar
  3. 3.
    Christaki E, Opal S (2008) Is the mortality rate for septic shock really decreasing? Curr Opin Crit Care 14:580–586CrossRefPubMedGoogle Scholar
  4. 4.
    Alberti C, Brun-Buisson C, Burchardi H et al (2002) Epidemiology of sepsis and infection in ICU patients from an international multicentre cohort study. Intensive Care Med 28:108–121CrossRefPubMedGoogle Scholar
  5. 5.
    Friedman G, Silva E, Vincent JL (1998) Has the mortality of septic shock changed with time. Crit Care Med 26:2078–2086CrossRefPubMedGoogle Scholar
  6. 6.
    Dellinger RP, Carlet JM, Masur H et al (2004) Surviving Sepsis Campaign: Guidelines for management of severe sepsis and septic shock. Intensive Care Med 30:536–555CrossRefPubMedGoogle Scholar
  7. 7.
    Dellinger RP, Levy MM, Carlet MM et al (2008) Surviving Sepsis Campaign: International guidelines for management of severe sepsis and septic shock. Crit Care Med 36:296–327CrossRefPubMedGoogle Scholar
  8. 8.
    Bone RC, Balk RA, Cerra FB et al (1992) Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 101:1644–1655CrossRefPubMedGoogle Scholar
  9. 9.
    Levy MM, Fink MP, Marshall JC et al (2003) 2001 SCCM/ESICM/ACCP/ATS/SIS. International Sepsis Definitions Conference. Crit Care Med 31:1250–1256CrossRefPubMedGoogle Scholar
  10. 10.
    Chan YL, Tseng CP, Tseg PK et al (2004) Procalcitonin as a marker of bacterial infection in the emergency department: An observational study. Crit Care 8:R12–R20CrossRefPubMedGoogle Scholar
  11. 11.
    Lobo SM, Lobo FR, Bota DP et al (2003). C-reactive protein levels correlate with mortality and organ failure in critically ill patients. Chest 123:2043–2049CrossRefPubMedGoogle Scholar
  12. 12.
    Martini A, Gottin L, Mélot C et al (2008) A prospective evaluation of the infection probability score (IPS) in the intensive care unit. J Infect 56:313–318CrossRefPubMedGoogle Scholar
  13. 13.
    Ince C (2005) The microcirculation is the motor of sepsis. Crit Care 4:S13–S19CrossRefGoogle Scholar
  14. 14.
    Spronk PE, Zandstra DF, Ince C (2004) Bench-to-bedside review: Sepsis is a disease of the microcirculation. Crit Care 8:462–468CrossRefPubMedGoogle Scholar
  15. 15.
    Fink MP (2002) Cytopathic hypoxia. Is oxygen use impaired in sepsis as a result of an acquired intrinsic derangement in cellular respiration? Crit Care Clin 18:165–175CrossRefPubMedGoogle Scholar
  16. 16.
    Singer M (2008) Cellular dysfunction in sepsis. Clin Chest Med 29:655–660CrossRefPubMedGoogle Scholar
  17. 17.
    Nin N, Cassina A, Boggia J et al (2004) Septic diaphragmatic dysfunction is prevented by Mn(III) porphyrin therapy and inducible nitric oxide synthase inhibition. Intensive Care Med 30:2271–2278CrossRefPubMedGoogle Scholar
  18. 18.
    Bihari D (1989) Encephalopathy associated with sepsis. In Bihari D, Holaday JW (eds) Update in intensive care and emergency medicine. Brain failure. Springer-Verlag, Berlin, pp 145–163Google Scholar
  19. 19.
    Amaral A, Opal S, Vincent JL (2004) Coagulation in sepsis. Intensive Care Med 30:1032–1040CrossRefPubMedGoogle Scholar
  20. 20.
    Marshall JC, Cook DJ, Christou NV et al (1995) Multiple organ dysfunction score: A reliable descriptor of a complex clinical outcome. Crit Care Med 23:1638–1652CrossRefPubMedGoogle Scholar
  21. 21.
    Vincent J, Moreno R, Takala J et al (1996) The SOFA (Sepsis Related Organ Failure Assessement) Score to describe organ dysfunction failure. Intensive Care Med 22:707–710CrossRefPubMedGoogle Scholar
  22. 22.
    Brun Buisson Ch, Doyon F, Carlet J et al (1995) Incidence, risk factors, and outcome of severe sepsis and septic shock in adults. JAMA 274:968–974CrossRefPubMedGoogle Scholar
  23. 23.
    Barenfanger J, Graham D, Lavanya K et al (2008) Decreased mortality associated with prompt gram staining of blood cultures. Am J Clin Pathol 130:870–876CrossRefPubMedGoogle Scholar
  24. 24.
    Uzzan B, Cohen R, Nicolas P et al (2007) Procalcitonin as a diagnostic test for sepsis in critically ill adults and alter surgery or trauma: A systematic review and meta-analysis. Crit Care Med 34:1996–2003CrossRefGoogle Scholar
  25. 25.
    Andrejaitiene J (2006) The diagnostic value of procalcitonin in severe sepsis. Medicina (Kaunas) 42:69–78Google Scholar
  26. 26.
    Shapiro NI, Trezeciak S, Hollander J (2009) A prospective, multicenter derivation of a biomarker panel to assess risk of organ dysfunction, shock, and death in emergency department patients with suspected sepsis. Crit Care Med 37:96–104CrossRefPubMedGoogle Scholar
  27. 27.
    Rivers E, Nguyen B, Havstad S et al (2001) Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 345:1368–1377CrossRefPubMedGoogle Scholar
  28. 28.
    Rivers E, Coba V, Whitmill M (2008). Early goal-directed therapy in severe sepsis and septic shock: A contemporary review of the literature. Curr Opin Anaesthesiol 21:128–140CrossRefPubMedGoogle Scholar
  29. 29.
    Rivers EP, Coba V, Visbal A et al (2008) Management of sepsis: Early resuscitation. Clin Chest Med 29:689–704CrossRefPubMedGoogle Scholar
  30. 30.
    Cook D, Guyatt G (2001) Colloid use for fluid resuscitation: Evidence and spin. Ann Intern Med 135:205–208PubMedGoogle Scholar
  31. 31.
    Kellum J, Decker J (2001) Use of dopamine in acute renal failure: A meta-analysis. Crit Care Med 29:1526–1531CrossRefPubMedGoogle Scholar
  32. 32.
    Kumar A, Roberts D, Wood KE et al (2006) Duration of hypotension prior to initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med 34:1589–1596CrossRefPubMedGoogle Scholar
  33. 33.
    Ibrahim EH, Sherman G, Ward S et al (2001) The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting. Chest 118:146–155CrossRefGoogle Scholar
  34. 34.
    Martin JB, Wheeler AP (2009) Approach to the patient with sepsis. Clin Chest Med 30:1–16CrossRefPubMedGoogle Scholar
  35. 35.
    Annane D, Sebille V, Charpentier C et al (2002) Effect of treatment with low doses of hydrocortisone and fludrocortisone on mortality in patients with septic shock. JAMA 288:862–871CrossRefPubMedGoogle Scholar
  36. 36.
    Sprung CL, Annane D, Keh D et al (2008) Hydrocortisone therapy for patients with septic shock. N Engl J Med 358:111–124CrossRefPubMedGoogle Scholar
  37. 37.
    The Acute Respiratory Distress Syndrome Network (2000) Ventilation with lower tidal volumes as compared with traditional tidal volumes for acute lung injury and the acute respiratory distress syndrome. N Engl J Med 342:1301–1308CrossRefGoogle Scholar
  38. 38.
    Van den Berghe G, Wouters P, Weekers F et al (2001) Intensive insulin therapy in critically ill patients. N Engl J Med 345:1359–1367CrossRefPubMedGoogle Scholar
  39. 39.
    Van den Berghe G, Wilmer A, Hermans G et al (2006) Intensive insulin therapy in the medical ICU. N Engl J Med 354:449–461CrossRefPubMedGoogle Scholar
  40. 40.
    Intensive versus conventional glucose control in critically ill patients (2009) The NICE-SUGAR Study Investigators. New Engl J Med 360:1283–1297CrossRefGoogle Scholar
  41. 41.
    Bernard GR, Vincent JL, Laterre PF et al (2001) Efficacy and safety of recombinant human activated protein C for severe sepsis. N Engl J Med 344:699–709CrossRefPubMedGoogle Scholar
  42. 42.
    Abraham E, Laterre PF, Garg R, et al (2005) Drotrecogin alfa (activated) for adults with severe sepsis and a low risk of death. N Engl J Med 353:1332–1341CrossRefPubMedGoogle Scholar
  43. 43.
    Vincent JL, Bernard GR, Beale R, et al (2005) Drotrecogin alfa (activated) treatment in severe sepsis from the global open-label trial ENHANCE: Further evidence for survival and safety and implications for early treatment. Crit Care Med 33:2266–2277CrossRefPubMedGoogle Scholar
  44. 44.
    Kellum JA, Angus DC, Johnson JP, et al (2002) Continuous versus intermittent renal replacement therapy: A meta-analysis. Intensive Care Med 28:29–37CrossRefPubMedGoogle Scholar
  45. 45.
    Tonelli M, Manns B, Feller-Kopman D (2002) Acute renal failure in the intensive care unit: A systematic review of the impact of dialytic modality on mortality and renal recovery. Am J Kidney Dis 40:875–885CrossRefPubMedGoogle Scholar
  46. 46.
    Palevsky PM, Zhang JH, O’Connor TZ, et al (2008) The VA/NIH Acute Renal Failure Trial Network: Intensity of renal support in critically ill patients with acute kidney injury. N Engl J Med 359:7–20CrossRefPubMedGoogle Scholar
  47. 48.
    Levy MM, Pronovost PJ, Dellinger RP et al (2004) Sepsis change bundles: Converting guidelines into meaningful change in behavior and clinical outcome. Crit Care Med 32:S595–S597CrossRefPubMedGoogle Scholar
  48. 50.
    Gao F, Melody T, Daniels DF et al (2005) The impact of compliance with 6-hour and 24-hour sepsis bundle on hospital mortality in patients with severe sepsis: A prospective observational study. Crit Care 9:R764–R770CrossRefPubMedGoogle Scholar
  49. 51.
    Zambon M, Ceola M, Almeida-de-Castro R et al (2008) Implementation of the Surviving Sepsis Campaign guidelines for severe sepsis and septic shock: We could go faster. J Crit Care 23:455–460CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag Italia 2009

Authors and Affiliations

  • F. J. Hurtado
    • 1
    • 2
  • M. Buroni
    • 1
  • J. Tenzi
    • 1
  1. 1.Intensive Care Medicine Unit, Hospital Español “Juan J. Crottogini”ASSEMontevideoUruguay
  2. 2.Department of Pathophysiology, School of MedicineUniversidad de la RepúblicaMontevideoUruguay

Personalised recommendations